Kassler-Taub Kenneth B. 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+7,086→ 111,186 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−18,243→ 0 total→ Common Stock (18,243 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−27,557→ 55,113 total→ Common Stock (27,557 underlying) - Exercise/Conversion
Common Stock
2023-02-28+18,243→ 104,100 total - Exercise/Conversion
Common Stock
2023-02-28+27,557→ 138,743 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−7,086→ 7,087 total→ Common Stock (7,086 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−19,118$41,486→ 119,625 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.